OGI
Price
$1.35
Change
+$0.04 (+3.05%)
Updated
Jun 6 closing price
Capitalization
200.85M
SIGA
Price
$6.03
Change
+$0.15 (+2.55%)
Updated
Jun 6 closing price
Capitalization
608.54M
54 days until earnings call
Interact to see
Advertisement

OGI vs SIGA

Header iconOGI vs SIGA Comparison
Open Charts OGI vs SIGABanner chart's image
Organigram Global
Price$1.35
Change+$0.04 (+3.05%)
Volume$667.21K
Capitalization200.85M
SIGA Technologies
Price$6.03
Change+$0.15 (+2.55%)
Volume$385.58K
Capitalization608.54M
OGI vs SIGA Comparison Chart
Loading...
OGI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SIGA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
OGI vs. SIGA commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OGI is a Hold and SIGA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 07, 2025
Stock price -- (OGI: $1.35 vs. SIGA: $6.03)
Brand notoriety: OGI and SIGA are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: OGI: 129% vs. SIGA: 71%
Market capitalization -- OGI: $200.85M vs. SIGA: $608.54M
OGI [@Pharmaceuticals: Other] is valued at $200.85M. SIGA’s [@Pharmaceuticals: Other] market capitalization is $608.54M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OGI’s FA Score shows that 0 FA rating(s) are green whileSIGA’s FA Score has 2 green FA rating(s).

  • OGI’s FA Score: 0 green, 5 red.
  • SIGA’s FA Score: 2 green, 3 red.
According to our system of comparison, SIGA is a better buy in the long-term than OGI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

OGI’s TA Score shows that 2 TA indicator(s) are bullish while SIGA’s TA Score has 3 bullish TA indicator(s).

  • OGI’s TA Score: 2 bullish, 6 bearish.
  • SIGA’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, SIGA is a better buy in the short-term than OGI.

Price Growth

OGI (@Pharmaceuticals: Other) experienced а 0.00% price change this week, while SIGA (@Pharmaceuticals: Other) price change was +0.84% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +78.59%. For the same industry, the average monthly price growth was +15.33%, and the average quarterly price growth was +66.92%.

Reported Earning Dates

OGI is expected to report earnings on May 12, 2025.

SIGA is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+78.59% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SIGA($609M) has a higher market cap than OGI($201M). SIGA YTD gains are higher at: 10.802 vs. OGI (-16.149). SIGA has higher annual earnings (EBITDA): 84.2M vs. OGI (-195.74M). SIGA has more cash in the bank: 150M vs. OGI (42.3M). OGI has less debt than SIGA: OGI (136K) vs SIGA (564K). OGI has higher revenues than SIGA: OGI (161M) vs SIGA (140M).
OGISIGAOGI / SIGA
Capitalization201M609M33%
EBITDA-195.74M84.2M-232%
Gain YTD-16.14910.802-149%
P/E RatioN/A9.24-
Revenue161M140M115%
Total Cash42.3M150M28%
Total Debt136K564K24%
FUNDAMENTALS RATINGS
OGI vs SIGA: Fundamental Ratings
OGI
SIGA
OUTLOOK RATING
1..100
1520
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
2
Undervalued
PROFIT vs RISK RATING
1..100
10086
SMR RATING
1..100
9238
PRICE GROWTH RATING
1..100
4749
P/E GROWTH RATING
1..100
4321
SEASONALITY SCORE
1..100
n/a20

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SIGA's Valuation (2) in the Pharmaceuticals Other industry is somewhat better than the same rating for OGI (50) in the null industry. This means that SIGA’s stock grew somewhat faster than OGI’s over the last 12 months.

SIGA's Profit vs Risk Rating (86) in the Pharmaceuticals Other industry is in the same range as OGI (100) in the null industry. This means that SIGA’s stock grew similarly to OGI’s over the last 12 months.

SIGA's SMR Rating (38) in the Pharmaceuticals Other industry is somewhat better than the same rating for OGI (92) in the null industry. This means that SIGA’s stock grew somewhat faster than OGI’s over the last 12 months.

OGI's Price Growth Rating (47) in the null industry is in the same range as SIGA (49) in the Pharmaceuticals Other industry. This means that OGI’s stock grew similarly to SIGA’s over the last 12 months.

SIGA's P/E Growth Rating (21) in the Pharmaceuticals Other industry is in the same range as OGI (43) in the null industry. This means that SIGA’s stock grew similarly to OGI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
OGISIGA
RSI
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
84%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
82%
Momentum
ODDS (%)
Bearish Trend 1 day ago
84%
Bullish Trend 1 day ago
82%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
69%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
79%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
78%
Advances
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 5 days ago
78%
Declines
ODDS (%)
Bearish Trend 6 days ago
86%
Bearish Trend 3 days ago
79%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
71%
View a ticker or compare two or three
Interact to see
Advertisement
OGI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SIGA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WXCRX13.730.03
+0.22%
William Blair Emerg Mkts ex China Gr R6
ECDIX17.51N/A
N/A
Eaton Vance Global Equity Income C
BMRRX35.95N/A
N/A
BlackRock Mid-Cap Growth Equity R
CDWFX11.98N/A
N/A
American Funds Dvlpg Wld Gr&Inc 529F1
PMIVX10.68N/A
N/A
Putnam Multi-Asset Income R6

SIGA and

Correlation & Price change

A.I.dvisor tells us that SIGA and EBS have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SIGA and EBS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SIGA
1D Price
Change %
SIGA100%
+2.55%
EBS - SIGA
33%
Poorly correlated
+9.59%
CRRTF - SIGA
26%
Poorly correlated
N/A
EVOK - SIGA
26%
Poorly correlated
-14.84%
OGI - SIGA
24%
Poorly correlated
+3.05%
AMRX - SIGA
24%
Poorly correlated
+6.28%
More